TrialPediatric nephrology (Berlin, Germany)2020

Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial.

Pietro Ravani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.